Coşkun Belgin, Ayhan Müge, Ulusoy Serap, Guner Rahmet
Ankara Bilkent City Hospital, 06700 Ankara, Turkey.
Antibiotics (Basel). 2024 Jun 27;13(7):599. doi: 10.3390/antibiotics13070599.
Diabetic foot infection (DFI) occurs frequently in patients, followed up with diabetic foot ulcers (DFU). For this reason, antibiotic treatment is often used in patients followed with DFU. Inappropriate use of antibiotics and increasing antibiotic resistance threaten public health. We aimed to investigate the microbial spectrum and antimicrobial resistance patterns isolated from diabetic foot infections in Turkey and help clinicians to choose optimal antibiotics empirically. : This study was planned as a retrospective, single-center, cross-sectional study. Two hundred sixty-two patients whose causative microorganism was isolated in culture of tissue between 1 January 2021 and 31 December 2022 were included in this study. Bacterial profile and antimicrobial resistance patterns were analyzed. Four hundred thirty two isolates from 262 patients isolated in culture of tissue were evaluated. Of these microorganisms, 57.60% were Gram-negative, 41.20% were Gram-positive bacteria, and 1.2% were spp. The most frequently detected Gram-positive microorganism was spp. Gram-negative microorganisms were () and (). Polymicrobial infections were observed in 40.5% of the patients. Methicillin-resistant spp. rate was 51.3%, while extended-spectrum beta-lactamase (ESBL) resistance for was 66.7%. Due to increasing antibiotic resistance rates, treatment of common infections becomes more difficult. Knowledge of the microbiological profile and antibiotic resistance patterns of patients with DFIs is useful to guide empirical therapy.
糖尿病足感染(DFI)在患者中频繁发生,常伴有糖尿病足溃疡(DFU)。因此,抗生素治疗常用于伴有DFU的患者。抗生素的不当使用和抗生素耐药性的增加威胁着公众健康。我们旨在调查土耳其糖尿病足感染分离出的微生物谱和抗菌药物耐药模式,以帮助临床医生凭经验选择最佳抗生素。:本研究计划为一项回顾性、单中心横断面研究。纳入了2021年1月1日至2022年12月31日期间在组织培养中分离出致病微生物的262例患者。分析了细菌谱和抗菌药物耐药模式。对262例患者组织培养中分离出的432株菌株进行了评估。在这些微生物中,57.60%为革兰氏阴性菌,41.20%为革兰氏阳性菌,1.2%为其他菌种。最常检测到的革兰氏阳性微生物是某菌属。革兰氏阴性微生物是某菌属(具体菌名)和某菌属(具体菌名)。40.5%的患者观察到多微生物感染。耐甲氧西林某菌属的比例为51.3%,而某菌属对超广谱β-内酰胺酶(ESBL)的耐药率为66.7%。由于抗生素耐药率不断上升,常见感染的治疗变得更加困难。了解DFI患者的微生物谱和抗生素耐药模式有助于指导经验性治疗。